skip to content

Cambridge Cardiovascular

 

Functional genomic screens and AI: a key partnership for successful therapeutic development.

CRISPR gene-editing and AI are crucial tools in the early stages of developing therapies for the treatment of human disease. Such screens generate myriad datapoints that humans are unable to sift through without computational input.

Please join us to learn how the Milner Therapeutics Institute uses both approaches and wide-reaching collaborations input into all stages of the translational pathway from Innovation through to patients and back.

Speakers:

Nicola McCarthy, Head of Research, Milner Therapeutics Institute, University of Cambridge

and

Namshik Han, Head of Computational Biology and AI, Milner Therapeutics Institute, University of Cambridge

This talk is free to attend for:

  • Cambridge Network members
  • Current staff and students of the University of Cambridge and of Anglia Ruskin University
  • Milner affiliates, Frame Shift companies and Consortium members

 

Please email louise.rushworth@cambridgenetwork.co.uk to sign up if you don't have a Cambridge Network login.

More information and registration at: cambridgenetwork.co.uk/events/functional-genomic-screens-and-ai-key-partnership-successful-therapeutic-development

Read more about Milner Therapeutics Institute research at: milner.cam.ac.uk/cpa/

16:30pm-19:00pm (presentations 17:00-18:00)

Date: 
Tuesday, 22 October, 2024 - 16:30 to 19:30
Event location: 
West Hub, JJ Thomson Avenue, Cambridge, CB3 0US

We connect cardiovascular researchers in Cambridge and beyond.

For inquiries about our research, website or joining Cambridge Cardiovascular please contact Dr Jane Sugars

Find us on LinkedIn

Find us on Bluesky

Our Newsletter

             Subscribe here

        Previous Newsletters

Find us on X

You need to be logged into X to see our feed here: